GINA FARRINGER: Open Payments
NPI 1104854504 · WENDELL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 14 payments from 8 companies in 2025. Trend: 2023 $807 · 2024 $789 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
| Abbott Laboratories | 1 | $70 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $14 |
Products named: ETERNA, Wegovy, AIRSUPRA, REXULTI, MOUNJARO, Ozempic, QULIPTA, OTEZLA.
Industry payments across NC — which companies pay providers there.
